Dan Malarek, current CEO of Foundation Medicine Inc., appointed President and CEO of Roche Diagnostics North America, effective August 1, 2026 Malarek succeeds Brad Moore, who will retire at the end of July following nearly a decade of distinguished service at Roche Antonio Vergara appointed Chief Commercial Officer to lead U.S. commercial business units INDIANAPOLIS […]
Adam Brown has been appointed Managing Director, assuming responsibility for the day-to-day leadership of the business As part of the transition, Richard Brown will become Chairman after 26 years as Managing Director, while John Clapham will continue supporting the company in his role as Founder. The changes reflect a planned succession process that combines continuity, […]
TriLink’s Complete Portfolio of CleanCap® Analogs are Patented in Major Jurisdictions Globally; TriLink is the Sole Authorized Manufacturer of CleanCap® Capping Analogs SAN DIEGO — TriLink BioTechnologies, LLC (TriLink®), a Maravai LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has been granted a new patent from the China National Intellectual […]
Brings decentralized, in-house DNA synthesis capabilities to researchers in a rapidly growing biotechnology market Paris, France DNA Script, the programmable biology company developing next-generation enzymatic DNA synthesis (EDS) technologies, today announced a new distribution agreement with Imperial Life Sciences (ILS), expanding access to the Company’s SYNTAX® platform across India. Under the agreement, ILS will distribute […]
New Juno Bio lab infrastructure marks a major step in scaling provider-led care and advancing precision vaginal microbiome testing OAKLAND, Calif. — Juno Bio, a women’s health company dedicated to closing the gender health gap through precision vaginal microbiome testing and multi-omics, today announced the opening of its first sequencing lab built entirely for women’s […]
Researchers across Asia-Pacific gain a new option for high-quality single cell sequencing through Garvan’s Evercode WT services SEATTLE — Parse Biosciences, a QIAGEN company, and the leader in scalable and accessible single cell sequencing, today announced that the Genomics Platform Core Facility within the Garvan Institute of Medical Research has joined its Certified Service Provider […]
BREMEN, Germany — Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of the DISQVER® clinical metagenomics platform from Noscendo GmbH. The DISQVER® platform provides advanced bioinformatics and reporting to support rapid and comprehensive WGS analysis directly from cell-free human blood samples DISQVER® enables metagenomic next-generation sequencing (mNGS) analysis of microbes directly from blood samples, further expanding Bruker’s NGS-based […]
$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy SAN DIEGO — Primrose Bio, Inc., a company with proprietary biologic manufacturing technologies, today announced a $2 million, 24-month Direct-to-Phase II Small Business Innovation Research award from the National Center for Advancing Translational Sciences (NCATS), part of the […]
this appointment reflects the company’s continued growth through investment in leadership that pairs deep scientific credibility with real-world R&D experience SAN DIEGO — Rancho BioSciences today announced the appointment of John Reynders, PhD, MBA, to its Board of Directors. In his board role, Dr. Reynders will bring strategic depth to Rancho’s product direction and growth […]
Munich Regional Court finds Illumina infringes Element sequencing intellectual property, enjoins supply of Illumina systems and related consumables, and orders recall of affected devices SAN DIEGO, CA — Element Biosciences, Inc. today announced that the Regional Court of Munich I (Landgericht München I) has ruled that Illumina, Inc. and its German subsidiary, Illumina GmbH, infringe […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
